Reach out to the Acquis team
Innovation is accelerating, biotech investment is fragmenting, and market conditions are splintering under the weight of geopolitical, economic, and regulatory disruption. The companies that once defined the top of the market are no longer guaranteed to stay there. And the old playbook — great science plus patient capital equals growth — no longer works.
Read More
In the era of artificial intelligence, does private equity’s classic value creation playbook — operational improvements, margin expansion, and multiple arbitrage — still hold up?
Read More
Strategic planning often begins with a spark. Leadership teams rally around a bold vision. The room buzzes with optimism and alignment. But six months later, that energy fades. Teams scramble, timelines slip, and a familiar question resurfaces: Why isn’t our strategy working?
Read More
Innovation is accelerating, biotech investment is fragmenting, and market conditions are splintering under the weight of geopolitical, economic, and regulatory disruption. The companies that once defined the top of the market are no longer guaranteed to stay there. And the old playbook — great science plus patient capital equals growth — no longer works.
Read More
In the era of artificial intelligence, does private equity’s classic value creation playbook — operational improvements, margin expansion, and multiple arbitrage — still hold up?
Read More
Strategic planning often begins with a spark. Leadership teams rally around a bold vision. The room buzzes with optimism and alignment. But six months later, that energy fades. Teams scramble, timelines slip, and a familiar question resurfaces: Why isn’t our strategy working?
Read More
